127 related articles for article (PubMed ID: 20737520)
1. Serotonergic modulation of response inhibition and re-engagement? Results of a study in healthy human volunteers.
Drueke B; Boecker M; Schlaegel S; Moeller O; Hiemke C; Gründer G; Gauggel S
Hum Psychopharmacol; 2010 Aug; 25(6):472-80. PubMed ID: 20737520
[TBL] [Abstract][Full Text] [Related]
2. The role of 5-HT in response inhibition and re-engagement.
Drueke B; Schlaegel SM; Seifert A; Moeller O; Gründer G; Gauggel S; Boecker M
Eur Neuropsychopharmacol; 2013 Aug; 23(8):830-41. PubMed ID: 23816061
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study.
Drueke B; Baetz J; Boecker M; Moeller O; Hiemke C; Gründer G; Gauggel S
Psychopharmacology (Berl); 2009 Dec; 207(2):213-23. PubMed ID: 19756527
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease.
Ye Z; Altena E; Nombela C; Housden CR; Maxwell H; Rittman T; Huddleston C; Rae CL; Regenthal R; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
Brain; 2014 Apr; 137(Pt 4):1145-55. PubMed ID: 24578545
[TBL] [Abstract][Full Text] [Related]
5. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.
Bari A; Eagle DM; Mar AC; Robinson ES; Robbins TW
Psychopharmacology (Berl); 2009 Aug; 205(2):273-83. PubMed ID: 19404616
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability.
Nandam LS; Hester R; Wagner J; Cummins TD; Garner K; Dean AJ; Kim BN; Nathan PJ; Mattingley JB; Bellgrove MA
Biol Psychiatry; 2011 May; 69(9):902-4. PubMed ID: 21193172
[TBL] [Abstract][Full Text] [Related]
7. Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI.
Wingen M; Kuypers KP; Ramaekers JG
J Psychopharmacol; 2007 Jul; 21(5):477-85. PubMed ID: 17092965
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical modulation of response inhibition and probabilistic learning in humans.
Chamberlain SR; Müller U; Blackwell AD; Clark L; Robbins TW; Sahakian BJ
Science; 2006 Feb; 311(5762):861-3. PubMed ID: 16469930
[TBL] [Abstract][Full Text] [Related]
9. The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
Wingen M; Kuypers KP; Ramaekers JG
Psychopharmacology (Berl); 2007 Feb; 190(3):391-400. PubMed ID: 17124621
[TBL] [Abstract][Full Text] [Related]
10. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.
Windischberger C; Lanzenberger R; Holik A; Spindelegger C; Stein P; Moser U; Gerstl F; Fink M; Moser E; Kasper S
Neuroimage; 2010 Jan; 49(2):1161-70. PubMed ID: 19833214
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.
Nadeem HS; Attenburrow MJ; Cowen PJ
Neuropsychopharmacology; 2004 Sep; 29(9):1699-703. PubMed ID: 15127082
[TBL] [Abstract][Full Text] [Related]
12. Blunted autonomic reactivity to pharmacological panic challenge under long-term escitalopram treatment in healthy men.
Agorastos A; Kellner M; Stiedl O; Muhtz C; Wiedemann K; Demiralay C
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522396
[TBL] [Abstract][Full Text] [Related]
13. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
[TBL] [Abstract][Full Text] [Related]
14. The effects of increased central serotonergic activity on prepulse inhibition and habituation of the human startle response.
Jensen KS; Oranje B; Wienberg M; Glenthøj BY
Neuropsychopharmacology; 2007 Oct; 32(10):2117-24. PubMed ID: 17299503
[TBL] [Abstract][Full Text] [Related]
15. Serotonin depletion impairs waiting but not stop-signal reaction time in rats: implications for theories of the role of 5-HT in behavioral inhibition.
Eagle DM; Lehmann O; Theobald DE; Pena Y; Zakaria R; Ghosh R; Dalley JW; Robbins TW
Neuropsychopharmacology; 2009 Apr; 34(5):1311-21. PubMed ID: 19005464
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain.
El Mansari M; Sánchez C; Chouvet G; Renaud B; Haddjeri N
Neuropsychopharmacology; 2005 Jul; 30(7):1269-77. PubMed ID: 15702136
[TBL] [Abstract][Full Text] [Related]
17. Acute 5-HT reuptake blockade potentiates human amygdala reactivity.
Bigos KL; Pollock BG; Aizenstein HJ; Fisher PM; Bies RR; Hariri AR
Neuropsychopharmacology; 2008 Dec; 33(13):3221-5. PubMed ID: 18463627
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Escitalopram on Central Serotonergic and Dopaminergic Systems in Patients with Cervical Dystonia, and Its Relationship with Clinical Treatment Effects: A Double-Blind Placebo-Controlled Trial.
Zoons E; Tijssen MAJ; Dreissen YEM; Smit M; Booij J
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32521736
[No Abstract] [Full Text] [Related]
19. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels.
Bundgaard C; Larsen F; Jørgensen M; Gabrielsson J
Eur J Pharm Sci; 2006 Dec; 29(5):394-404. PubMed ID: 17014998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
